Severe lupus nephritis: importance of re-evaluating the histologic classification and the approach to patient care

被引:0
|
作者
Lewis, EJ
Schwartz, MM
Korbet, SM
机构
[1] Rush Presbyterian St Lukes Med Ctr, Nephrol Sect, Dept Med, Chicago, IL 60612 USA
[2] Rush Presbyterian St Lukes Med Ctr, Dept Pathol, Chicago, IL 60612 USA
关键词
systemic lupus erythematosus; lupus nephritis; segmental glomerulonephritis; diffuse prolyferative glomerulonephritis;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The histopathology of severe lupus glomerulonephritis comprises distinct patterns of injury which were initially defined by the World Health Organization Classification of 1982 as focal and segmental glomerulonephritis (category III), diffuse proliferative glomerulonephritis (category IV) and complex membranous glomerulonephritis (categories Vc, Vd). It is assumed that the morphologic abnormalities demonstrated in this classification represent distinctive differences in the mediation of the immune response which leads to a specific type of glomerular inflammation. In 1995 the World Health Organizational committee recommended a change in categorization of focal and segmental glomerulonephritis (class III) and diffuse proliferative glomerulonephritis (class IV), which would overlook the morphological differences between these categories and treat them as a continuum, recommending that biopsies classified as focal and segmental glomerulonephritis (category III) with involvement of greater than or equal to 50% of glomeruli be included into the diffuse proliferative glomerulonephritis category (category IV). Since the classification of severe lupus nephritis has significant impact on prognosis and the therapeutic approach to patients with this disease, it is the purpose of this review to critically re-examine the existing classification based on new insights into differences in morphologic features and long-term outcome.
引用
收藏
页码:223 / 227
页数:5
相关论文
共 50 条
  • [21] Re-Evaluating Psychotropic Drug Use Across Care Settings
    Gnjidic, Danijela
    Bell, J. Simon
    Hilmer, Sarah N.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 (09) : 1640 - 1640
  • [22] Re-evaluating green marketing - A sophisticated strategic marketing approach
    Polonsky, MJ
    Rosenberger, PJ
    2000 AMA EDUCATORS' PROCEEDINGS - ENHANCING KNOWLEDGE DEVELOPMENT IN MARKETING, 2000, : 313 - 313
  • [23] Re-Evaluating a Standard Approach to Assessing Glucose Monitor Performance
    Baum, John M.
    Pardo, Scott A.
    Schachner, Holly C.
    Parkes, Joan Lee
    Simmons, David A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (05) : 323 - 325
  • [24] Care about the flare: the importance of avoiding lupus nephritis recurrence
    Weinmann-Menke, Julia
    Kraus, Daniel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (04) : 800 - 802
  • [25] GP-patient communication about possible cancer in primary care: Re-evaluating GP as gatekeeper
    Brindle, L. A.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (03)
  • [26] Mizoribine oral pulse therapy for a patient with severe lupus nephritis
    Tanaka, H
    Suzuki, K
    Nakahata, T
    Sato, T
    Ito, E
    PEDIATRICS INTERNATIONAL, 2003, 45 (04) : 488 - 490
  • [27] SALMONELLA ARTHRITIS IN A PATIENT WITH SEVERE LUPUS NEPHRITIS AND THALASSEMIA MINOR
    KRUMME, B
    CONCA, W
    BALLE, C
    PETER, HH
    SCHOLLMEYER, P
    NEPHRON, 1995, 71 (04) : 465 - 467
  • [28] Severe and prolonged jaundice in a lupus nephritis patient treated with cyclophosphamide
    Moroni, G
    Maccario, M
    Fargion, S
    Ponticelli, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (04) : 793 - 796
  • [29] Re-evaluating gender differences in self-rated health: The importance of cohort
    Etherington, Nicole
    JOURNAL OF WOMEN & AGING, 2017, 29 (02) : 150 - 162
  • [30] Re-Evaluating Nurse-Patient Ratios: Beyond the Numbers and the Law
    Nickitas, Donna M.
    NURSING ECONOMICS, 2010, 28 (02): : 73 - +